About High Throughput Process Development
The ability to run multiple trials in tandem greatly decreases the time it takes to create a biopharmaceutical production method. Since process production and manufacturing are on the "key road" for a drug candidate to reach clinical development, this is especially important before clinical entry. During late-stage growth, high-throughput process development (HTPD) methodologies may have a related effect, both in terms of designing the final commercial process and in terms of process characterization and scale-down evaluation activities, which are both important parts of the licensure filing kit. Method engineering has always been a critical component of competitive bioprocess scaling-up to industrial manufacturing scale.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global High Throughput Process Development market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Danaher Corporation (United States), GE Healthcare (United States), Agilent Technologies (United States), Merck Millipore (Germany), Thermo Fisher Scientific (United States), Sartorius Stedim Biotech (Germany), Bio-Rad Laboratories (United States), Eppendorf AG (Germany) and Perkinelmer, Inc (United Kingdom) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global High Throughput Process Development market by Type (Consumables (Miniature Prepacked Columns, Micro-well Filter Plates, Miniature Disposable Bioreactor, Micropipettes and Pipette Tips), Instruments, Automatic Integrated Workstation, Automated Miniature Bioreactor System, Services and Software), Application (Monoclonal Antibodies and Recombinant Insulin) and Region.
On the basis of geography, the market of High Throughput Process Development has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Chromatography will boost the High Throughput Process Development market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Use, the sub-segment i.e. Biopharmaceutical Companies will boost the High Throughput Process Development market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Rising Implementation of Quality by Design (QBD) Principles
Market Growth Drivers:
Demand for Biopharmaceuticals and Technical Progress in High Throughput Process Development
Challenges:
Lack of Trained Professionals
Restraints:
High Initial Investments
Opportunities:
Low Penetration in Emerging Regions Particularly Asia and Growing Healthcare Infrastructure
In October 2023 , Sartorius Stedim Biotech (SSB) launched of the ambr 250 high throughput (ht) perfusion bioreactor. This is a new automated parallel bioreactor system specially designed for rapid cell culture perfusion process development to optimize production of therapeutic antibodies.
Key Target Audience
Biopharmaceutical Manufactures, High Throughput Process Development Institutions, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.